-
, computational drug repurposing, and de novo design of novel protein-based therapeutics. Our work also includes developing gene editing strategies to correct or inactivate mutations associated with severe
-
of nucleic acid sensing via cGAS/STING and RIG-like receptor pathways in hereditary inflammatory diseases culminating the development of therapeutically relevant drugs (Haag et al., 2018 Nature, Dressel et al
-
of nucleic acid sensing via cGAS/STING and RIG-like receptor pathways in hereditary inflammatory diseases culminating the development of therapeutically relevant drugs (Haag et al., 2018 Nature, Dressel et al
-
to publications and grant writing, and support the supervision of students and junior researchers in one the following research areas: Computational oncology AI drug discovery Statistical genetics, single-cell
-
organism through production of bioactive secondary metabolites, ii) to identify their potential drug discovery against human diseases. Several microbial cultivation approaches, such as one-microbe-at-a-time